A comparison of the clinical features and comorbidities of psoriasis and psoriatic arthritis: A retrospective study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Oh, Eui Hyun | - |
dc.contributor.author | Park, Byeong Jin | - |
dc.contributor.author | Kwon, Hyoung II | - |
dc.contributor.author | Kim, Jeong Eun | - |
dc.contributor.author | Ko, Joo Yeon | - |
dc.contributor.author | Ro, Young Suck | - |
dc.date.accessioned | 2022-07-15T07:12:56Z | - |
dc.date.available | 2022-07-15T07:12:56Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2016-09 | - |
dc.identifier.issn | 0494-4739 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/153995 | - |
dc.description.abstract | Background: Psoriatic arthritis (PsA) is one of the inflammatory arthritis associated with psoriasis. Several studies have described the clinical difference between psoriatic patients with PsA and those without PsA. Objective: The purpose of this study was to examine the difference in clinical features and prevalence of comorbidities between psoriatic patients with and without PsA in Korea. Methods: We retrospectively evaluated 173 patients diagnosed with psoriasis. Patients were subdivided based on the presence or absence of PsA. We analyzed clinical manifestations including comorbidities and laboratory tests such as total cholesterol, triglyceride, C-reactive protein, erythrocyte sedimentation rate (ESR), and fasting glucose. Results: Among 173 patients with psoriasis, 29 patients (16.8%) were diagnosed with PsA. The mean age of psoriasis onset for patients with PsA was 7.6 years earlier (p=0.017) than for those without PsA. The duration of psoriasis was 4.6 years longer (p< 0.001) in patients with PsA than in patients without PsA. Nail involvement was more common in patients with PsA (p<0.001). There were statistically significant differences between the two groups regarding ESR levels (p=0.003) and the prevalence of diabetes mellitus (p=0.032). Conclusion: We found several differences in the prevalence of comorbidities, levels of inflammatory markers, and epidemiologic characteristics between psoriatic patients with and without PsA. This study may help improve strategies for the clinical approach for treating psoriasis in dermatology. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | Korean Dermatological Association | - |
dc.title | A comparison of the clinical features and comorbidities of psoriasis and psoriatic arthritis: A retrospective study | - |
dc.title.alternative | 건선 및 건선관절염에서 임상 양상과 동반질환에 대한 후향적 비교연구 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jeong Eun | - |
dc.contributor.affiliatedAuthor | Ko, Joo Yeon | - |
dc.contributor.affiliatedAuthor | Ro, Young Suck | - |
dc.identifier.scopusid | 2-s2.0-84995489516 | - |
dc.identifier.bibliographicCitation | Korean Journal of Dermatology, v.54, no.8, pp.608 - 613 | - |
dc.relation.isPartOf | Korean Journal of Dermatology | - |
dc.citation.title | Korean Journal of Dermatology | - |
dc.citation.volume | 54 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 608 | - |
dc.citation.endPage | 613 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002145035 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Clinical features | - |
dc.subject.keywordAuthor | Psoriasis | - |
dc.subject.keywordAuthor | Psoriatic arthritis | - |
dc.identifier.url | http://kiss.kstudy.com/thesis/thesis-view.asp?key=3466513 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.